(Bloomberg) — Three months ago, Arjun Vij couldn’t wait to sell all his junk bonds. Now he can’t get enough of them. In a strategy U-turn, Vij,...
(Bloomberg) — JPMorgan Asset Management now has more than $400 million in its Thematics – Genetic Therapies fund launched in October, just before the world’s need for...
